Project Grant R21AG091884
Award Date
6/1/25
Completion Date
5/31/27
Dollars Obligated
$413K
Federal Agency
National Institute on Aging
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Florida, USA
Similar Awards
This $420,750 Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) will support research at Texas Tech University Health Sciences Center (TTUHSC) to investigate the role of amyloids, including CRES proteins, and extracellular nucleic acids as components of the brain extracellular matrix (ECM). The key objectives are to: 1) establish that these biomolecules are present in the mouse and human brain ECM, and 2) determine the sex-specific contributions of...
This National Institute on Aging (NIA) Project Grant award under CFDA Program 93.866 "Aging Research" provides $254,250 to New York University (NYU) School of Medicine to develop a biologically relevant multi-scale model of brain aging using advanced diffusion MRI (dMRI) techniques. The project aims to create a brain microstructure age framework by generating brain charts of quantitative dMRI and mesoscopic MRI (mesoMRI) markers across the lifespan. It will evaluate the effects of...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $200,323 to the University of South Florida to investigate the aggregation of amyloid-beta (Aβ) peptides during metabolic stress and spreading depolarization events associated with various neurological conditions. The research will utilize multiscale modeling, high-resolution microscopy, and phenotypic testing in C. elegans to determine how changes in pH, ion concentrations, and Aβ levels in the...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 Aging Research) provides $205,619 to the University of Washington from September 2024 to June 2026 to map the landscape of the aged human brain and develop human-based neurodegenerative disease models. The project aims to leverage explainable artificial intelligence (XAI) methods and human brain 'omic data to identify molecular drivers of brain aging, which will then be manipulated in human induced pluripotent...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) in the amount of $804,795 will fund research to investigate the neural mechanisms underlying the relationship between gait and cognition in aging and Alzheimer's disease (AD)/Alzheimer's disease-related dementias (ADRD). The research team at the University of Florida will use cutting-edge mobile EEG and neuroimaging techniques to determine how changes in vestibular and hippocampal brain regions impact...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $1,829,859.00 to the University of Maryland, College Park to develop and validate a new proteomics platform called Scalable Single-Cell Mass Spectrometry (SCEMAS). The goal is to enable high-sensitivity mass spectrometry analysis of proteins and protein fragments associated with aging and neurodegenerative diseases, such as Alzheimer's, across different biological models including...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) totaling $794,341 will support research to investigate the mechanistic roles of cellular senescence and blood-brain barrier dysfunction in mediating pathogen-induced progression of Alzheimer's disease. The research will leverage experimental mouse models, molecular characterization of endogenous retrovirus RNA sensing, and human induced pluripotent stem cell (iPSC) models. Key objectives...
This $1,758,779 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will support research by the Winifred Masterson Burke Medical Research Institute to assess neuronal vulnerability in the entorhinal cortex due to Alzheimer's disease pathology. The key objectives are to determine whether hyperexcitability in Alzheimer's disease is caused by dysfunction of excitatory or inhibitory neurons in the entorhinal cortex, and to modulate neuronal activities to...
This federal Project Grant award of $768,427.00 from the National Institute on Aging (CFDA 93.866 Aging Research) supports a 3-year longitudinal study to determine the mechanisms linking midlife vascular risk factors with the early loss of brain tissue structure and cognitive function. The study aims to (1) investigate the early drivers of increased cerebrovascular pulsatility, (2) evaluate the spatial and temporal relationship between cerebrovascular pulsatility and brain tissue...
This $125,896 Project Grant, awarded by the National Institute on Aging under the Aging Research program (CFDA 93.866), supports a research project led by The Washington University in St. Louis. The project aims to utilize state-of-the-art single-nuclei multi-omic functional genomic analyses of healthy and Alzheimer's disease (AD) human brain tissue, as well as transgenic AD mouse models, to perform deep molecular characterization of AD risk and resilience pathways across genetic, epigenomic,...